Celularity Inc., a clinical-stage company developing allogeneic cellular therapies from human placentas, today announced the U.S. Food and Drug Administration ...
BARDA and Cue Health will collaborate to accelerate the development, validation, and manufacturing of a portable, molecular diagnostic test capable of ...
Sanofi Pasteur and Translate Bio this week announced plans to collaborate to develop a novel messenger RNA (mRNA) vaccine for COVID-19. ...
Gladstone Institutes scientists have rapidly pivoted the focus of their research labs to the novel virus, SARS-CoV-2. Specifically, they are ...
The University of Cambridge is to take a leading role in a major national effort to help understand and control ...
Gavi announces new measures to allow grant recipients to rapidly fill critical gaps by reallocating up to 10% of existing ...
First Rapid, Point-of-Care and Near-Patient Molecular Test for Detection of Virus that Causes COVID-19 Cepheid today announced it has received ...
Ventec Life Systems and GM in cooperation with StopTheSpread.org, the nation's coordinated private sector response to the COVID-19, are collaborating ...
Canon Medical Systems announced the start of development of a rapid genetic testing system for the novel coronavirus (COVID-19). This ...
Ridgeback Biotherapeutics and Drug Innovations at Emory (DRIVE) LLC, a not-for-profit biotechnology company wholly owned by Emory University, today announced ...
GenMark Diagnostics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for ...
Abbott announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular ...
Regeneron Pharmaceuticals, Inc. today announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that ...
PharmaJet has announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of ...
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of ...
Molecular diagnostics company Co-Diagnostics, Inc. announced today that a new FDA policy released last night aimed at expediting the availability ...
Companies will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection. Pfizer Inc. and BioNTech SE today announced ...
As doctors, scientists and governments try to get a grip on COVID-19, the University of Michigan startup Arbor Biosciences is ...
BD and BioGX Inc today announced that the companies have submitted Emergency Use Authorization requests to the U.S. Food and ...
U.S. Phase 2/3 trial initiated and will begin enrolling patients immediately Regeneron is leading U.S. trials, Sanofi will lead upcoming ex-U.S. trials Regeneron Pharmaceuticals, ...
